| Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance M Wickström, C Dyberg, J Milosevic, C Einvik, R Calero, ... Nature communications 6 (1), 1-10, 2015 | 220 | 2015 |
| Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo M Wickström, C Dyberg, T Shimokawa, J Milosevic, N Baryawno, ... International journal of cancer 132 (7), 1516-1524, 2013 | 138 | 2013 |
| Induction of a timed metabolic collapse to overcome cancer chemoresistance N van Gastel, JB Spinelli, A Sharda, A Schajnovitz, N Baryawno, C Rhee, ... Cell Metabolism 32 (3), 391-403. e6, 2020 | 101 | 2020 |
| Frequent detection of human cytomegalovirus in neuroblastoma: a novel therapeutic target? N Wolmer‐Solberg, N Baryawno, A Rahbar, D Fuchs, J Odeberg, C Taher, ... International journal of cancer 133 (10), 2351-2361, 2013 | 95 | 2013 |
| KAT6A and ENL form an epigenetic transcriptional control module to drive critical leukemogenic gene expression programs F Yan, J Li, J Milosevic, R Petroni, S Liu, Z Shi, S Yuan, JM Reynaga, Y Qi, ... Cancer discovery, 2021 | 38 | 2021 |
| Analysis of ALK, MYCN, and the ALK ligand ALKAL2 (FAM150B/AUGα) in neuroblastoma patient samples with chromosome arm 2p rearrangements N Javanmardi, S Fransson, A Djos, G Umapathy, M Östensson, ... Genes, Chromosomes and Cancer 59 (1), 50-57, 2020 | 33 | 2020 |
| DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma TK Olsen, C Dyberg, B Embaie, A Alchahin, J Milosevic, J Otte, ... bioRxiv, 2021 | 15 | 2021 |
| Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies J Milosevic, J Klinge, AL Borg, T Foukakis, J Bergh, NP Tobin BMC cancer 13 (1), 1-11, 2013 | 14 | 2013 |
| A new murine model of Barth Syndrome neutropenia links TAFAZZIN deficiency to increased ER stress induced apoptosis J Sohn, J Milosevic, T Brouse, N Aziz, J Elkhoury, S Wang, A Hauschild, ... Blood Advances, 2022 | 11 | 2022 |
| Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance. Nat Commun. 2015; 6: 8904 M Wickström, C Dyberg, J Milosevic, C Einvik, R Calero, ... | 7 | |
| PPM1D Is a Therapeutic Target in Childhood Neural Tumors J Milosevic, D Treis, S Fransson, G Gallo-Oller, B Sveinbjörnsson, ... Cancers 13 (23), 6042, 2021 | 6 | 2021 |
| High Expression of PPM1D Induces Tumors Phenotypically Similar to TP53 Loss-of-Function Mutations in Mice J Milosevic, S Fransson, M Gulyas, TK Olsen, G Gallo-Oller, D Treis, ... Cancers 13 (21), 5493, 2021 | 5 | 2021 |
| TC-hunter: identification of the insertion site of a transgenic gene within the host genome V Börjesson, A Martinez-Monleon, S Fransson, P Kogner, JI Johnsen, ... BMC genomics 23 (1), 1-11, 2022 | 1 | 2022 |
| 3012–PROBING HEMATOPOIETIC-STROMAL CROSSTALK BY SPATIALLY RESOLVED SINGLE-CELL RNA SEQ C Haase, K Gustafsson, SC Yeh, S Mei, J Milosevic, J Wu, D Sykes, ... Experimental Hematology 88, S41, 2020 | 1 | 2020 |
| PPM1D is a neuroblastoma oncogene and therapeutic target in childhood neural tumors. J Milosevic, S Fransson, M Gulyas, G Gallo-Oller, TK Olsen, D Treis, ... bioRxiv, 2020 | 1 | 2020 |
| Novel therapeutic targets in pediatric neural tumors J Milosevic Inst för kvinnors och barns hälsa/Dept of Women's and Children's Health, 2018 | 1 | 2018 |
| The PPM1D-encoded WIP1-phosphatase is a candidate oncogene on 17q contributing to neuroblastoma development and providing a novel therapeutic target J Milosevic, S Fransson, D Treis, K Tanino, M Wickstrom, ... PEDIATRIC BLOOD & CANCER 63, S82-S82, 2016 | 1 | 2016 |
| The cyclooxygenase-2 prostaglandin E2 pathway is expressed in childhood medulloblastoma providing novel therapeutic targets as indicated by promising response to Celecoxib … J Milosevic, N Baryawno, B Sveinbjornsson, S Eksborg, S Holm, ... CANCER RESEARCH 69, 2009 | 1 | 2009 |
| Hormone receptor expression in long-term estrogen deprived breast cancer cell lines in vitro J Milosevic, J Bergh Cancer Research 67 (9 Supplement), 1005-1005, 2007 | 1 | 2007 |
| PPM1D/Wip1, promising new target in childhood cancers neuroblastoma and medulloblastoma J Milosevic, N Eissler, D Treis, M Wicktröm, S Fransson, B Sveinbjornsson, ... Cancer Research 77 (13 Supplement), 1945-1945, 2017 | | 2017 |
